Peripheral neuropathy, a result of damage to peripheral nerves, often presents a diagnostic challenge due to its myriad etiologies and clinical manifestations. This article provides a comprehensive guide to evaluating this complex condition.
Peripheral neuropathy typically presents with symptoms such as numbness, tingling, pain, and weakness, predominantly in the hands and feet. The pattern and type of these symptoms can provide clues to the underlying cause. A careful history and physical examination, focusing on the pattern of symptom onset, distribution, progression, and associated systemic symptoms, are vital in the initial evaluation.
After the clinical evaluation, laboratory and imaging studies can help identify the etiology. Basic lab tests including complete blood count, metabolic panel, and vitamin B12 levels should be considered. Depending on the suspected cause, more specific tests such as genetic testing, autoimmune panels, or infectious disease tests may be needed. Nerve conduction studies and electromyography can help confirm the diagnosis and provide information about the severity and distribution of nerve damage.
In certain cases, a nerve or skin biopsy may be useful. A nerve biopsy can reveal axonal loss, demyelination, or vasculitis, while a skin punch biopsy can show loss of intraepidermal nerve fibers, indicative of small fiber neuropathy.
While diabetes is the most common cause of peripheral neuropathy, clinicians should consider less common etiologies, especially when the presentation is atypical or the patient does not respond to initial treatment. These include hereditary neuropathies, toxins, medications, and malignancies.
Evaluating peripheral neuropathy requires a systematic approach that includes a thorough clinical evaluation, appropriate laboratory and imaging studies, and consideration of both common and rare causes. By navigating this diagnostic maze, clinicians can identify the underlying cause and initiate appropriate treatment, improving outcomes for patients with this challenging condition.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation